Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US-Canada border

Open Medicine

Volumn 6, Issue 4, 2012, Pages 141-145

  Gomes, Tara ^a,b   Paterson, J Michael ^a,c,d   Juurlink, David N ^a,b,e,f   Dhalla, Irfan A ^a,f,g   Mamdani, Muhammad M ^a,f,g  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT; OXYCODONE;

ARTICLE; CANADA; DELAYED RELEASE FORMULATION; DRUG CONTROL; DRUG DATABASE; HUMAN; INTERNATIONAL COOPERATION; LEGAL ASPECT; METHODOLOGY; MIGRATION; PHARMACY; PRESCRIPTION; STATISTICS; UNITED STATES;

ANALGESICS, OPIOID; CANADA; DATABASES, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG AND NARCOTIC CONTROL; DRUG PRESCRIPTIONS; HUMAN MIGRATION; HUMANS; INTERNATIONALITY; OXYCODONE; PHARMACIES; UNITED STATES;

EID: 84870406000     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. MMWR Morb Mortal Wkly Rep 2011;60(43):1487-1492.
2. Opioid consumption motion chart. Madison (WI): University of Wisconsin, Pain and Policy Studies Group; 2009-2012. Available from: http://ppsg-production.heroku.com/chart(accessed 2012 Sep. 21). Based on data from the International Narcotics Control Board and United Nations population data.
3. Policy impact: prescription painkiller overdoses. Atlanta (GA): Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2011. Available from: www.cdc.gov/homeandrecreationalsafety/rxbrief/(accessed 2012 Sep. 13).
4. Jayawant SS, Balkrishnan R. The controversy surrounding OxyContin abuse: issues and solutions. Ther Clin Risk Manag 2005;1(2):77-82.
5. FDA approves new formulation for OxyContin [news release]. Silver Spring (MD): Food and Drug Administration; 2010. Available from: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm207480.htm (accessed 2012 Sep. 13).
6. Rivera JO, Ortiz M, Cardenas V. Cross-border purchase of medications and health care in a sample of residents of El Paso, Texas, and Ciudad Juarez, Mexico. J Natl Med Assoc 2009;101(2):167-173
7. Potter JE, White K, Hopkins K, Amastae J, Grossman D. Clinic versus over-the-counter access to oral contraception: choices women make along the US-Mexico border. Am J Public Health 2010;100(6):1130- 1136.
8. Border crossing/entry data. Washington (DC): Department of Transportation (US), Research and Innovative Technology Administration; 2011. Available from: www.bts.gov/programs/international/transborder/TBDR_BC/TBDR_BC_Index.html (accessed 2012 Sep. 13).
9. CompuScript [database]. IMS Health, IMS Brogan; 2012. Available from: http://imsbrogansolutions.com/main.php?i=6&t=services(accessed 2012 Sep. 13).
10. Fischer B, Jones W, Krahn M, Rehm J. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf 2011;20(12):1269-1277.
11. Yeaw J, Lee WC, Wolden ML, Christensen T, Groleau D. Cost of selfmonitoring of blood glucose in Canada among patients on an insulin regimen for diabetes. Diabetes Ther 2012;3(1):7.
12. Law MR, Ystma A, Morgan SG. The short-term impact of Ontario's generic pricing reforms. PLoS One 2011;6(7):e23030.
13. Population and dwelling counts, for Canada, provinces and territories, and forward sortation areas as reported by the respondents, 2006 Census- 100% data. Ottawa (ON): Statistics Canada; 2010. Available from: www12.statcan.ca/census-recensement/2006/dp-pd/hlt/97-550/Index.cfm?TPL=P1C&Page=RETR&LANG=Eng&T=1202&SR=76&S=0&O=A&RPP=25&PR=35&CMA=0 (accessed 2012 Sep. 13).
14. Michigan high intensity drug trafficking area. Drug market analysis 2010. 2010-R0813-014. Johnstown (PA): Department of Justice (US), National Drug Intelligence Center; 2010. Available from: www.justice.gov/archive/ndic/pubs40/40390/40390p.pdf (accessed 2012 Sep. 13).
15. New York/New Jersey high intensity drug trafficking area. Drug market analysis 2009. 2009-R0813-024. Johnstown (PA): Department of Justice (US), National Drug Intelligence Center; 2009. Available from: www.justice.gov/archive/ndic/pubs32/32784/32784p.pdf (accessed 2012 Sep. 13).